Simplex Trading
KIN

Simplex Trading’s Kindred Biosciences, Inc. KIN Stock Holding History

Simplex Trading’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38,000
Closed -$2K – 12019
2021
Q3 		$2K Hold
38,000
– – ﹤0.01% 9606
2021
Q2 		$348K Buy
38,000
+37,190
+4,591% +$216K ﹤0.01% 4731
2021
Q1 		$402K Buy
810
+766
+1,741% +$3.7K ﹤0.01% 3695
2020
Q4 		$18K Sell
44
-157
-78% -$639 ﹤0.01% 7059
2020
Q3 		$86K Buy
201
+141
+235% +$589 ﹤0.01% 5062
2020
Q2 		$26K Buy
60
+35
+140% +$156 ﹤0.01% 6040
2020
Q1 		$10K Buy
25
+15
+150% +$127 ﹤0.01% 6497
2019
Q4 		$8K Sell
10
-267
-96% -$2.08K ﹤0.01% 6526
2019
Q3 		$189K Buy
+277
New +$2.03K ﹤0.01% 3617
2019
Q1 		– Sell
-82
Closed -$89K – 8183
2018
Q4 		$89K Buy
+82
New +$1.03K ﹤0.01% 3958
2017
Q3 		– Sell
-98
Closed -$35K – 6940
2017
Q2 		$35K Buy
+98
New +$703 ﹤0.01% 2736

Simplex Trading's KIN Position: Q1 2021 in Review

Simplex Trading sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 10,979 shares — an estimated $53K sold.

Simplex Trading first reported a position in KIN in Q2 2015 and held it in 5 quarters. The position peaked at $47K in Q4 2020. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

  • Simplex Trading reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Simplex Trading sold 10,979 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $53K.
  • Simplex Trading first reported a position in Kindred Biosciences, Inc. in Q2 2015 and held it in 5 quarters.
  • Simplex Trading's Kindred Biosciences, Inc. position peaked at $47K in Q4 2020.
  • 84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Simplex Trading's 13F filing for Q1 2021, filed 26 Apr 2021.